Mankind Pharma Signs Non-Exclusive Patent License Agreement with Takeda to Commercialize Vonoprazan in India
Mumbai, July 16, 2024: Mankind Pharma Limited and Takeda Pharmaceutical Company Limited signed a Non-Exclusive Patent License Agreement for commercialising ‘Vonoprazan’ in the Indian market. The agreement allows Mankind Pharma…